LISDEXAMFETAMINE 60 MG CAPSULE

lisdexamfetamine dimesylate
$2.9487per EA
DEA Schedule CII

Strength

60 mg/1

NDC

00054037425

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

LISDEXAMFETAMINE DIMESYLATE

Approval Type

Generic (ANDA)

FDA Application

ANDA202827

On Market Since

8/25/2023

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price History

1W

0.0%

1M

+0.7%

3M

-2.8%

6M

-11.9%

1Y

-38.8%

3Y

N/A

5Y

N/A

All

-13.1%